Clinical trial

ITV Extension Study

NCT00332930

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-09-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2002-09-01Date precision: month

Registry last updated2007-02-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

Interventions

recombinant fowlpoxvirus (rFPV) expressing HIV gag-pol antigensBIOLOGICAL

HIV gag-pol antigens and interferon-gamma (IFN-y)BIOLOGICAL

Sponsors & collaborators

Kirby Institutelead sponsor

The University of New South Walescollaborator

Virax Pty. Ltd,collaborator

Mapped research locations

SydneyNew South Wales, Australia4 MelbourneVictoria, Australia2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00332930 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.